MedEquities Realty Trust Inc (MRT) Given Consensus Recommendation of “Hold” by Analysts

Shares of MedEquities Realty Trust Inc (NYSE:MRT) have received a consensus recommendation of “Hold” from the ten ratings firms that are presently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have issued a buy rating on the company. The average twelve-month target price among analysts that have covered the stock in the last year is $10.75.

A number of brokerages have weighed in on MRT. Zacks Investment Research lowered MedEquities Realty Trust from a “hold” rating to a “sell” rating in a research note on Friday, November 23rd. Raymond James decreased their target price on MedEquities Realty Trust from $12.00 to $10.00 and set a “buy” rating on the stock in a research note on Tuesday, November 20th. B. Riley decreased their target price on MedEquities Realty Trust from $12.00 to $11.00 and set a “buy” rating on the stock in a research note on Tuesday, November 13th. Citigroup upgraded MedEquities Realty Trust from a “sell” rating to a “neutral” rating and set a $9.00 target price on the stock in a research note on Monday, November 12th. Finally, JMP Securities set a $12.00 target price on MedEquities Realty Trust and gave the stock a “buy” rating in a research note on Tuesday, October 23rd.

NYSE MRT traded up $0.08 during trading on Monday, reaching $6.92. The company’s stock had a trading volume of 177,261 shares, compared to its average volume of 155,288. The firm has a market capitalization of $217.94 million, a P/E ratio of 6.07 and a beta of 0.58. MedEquities Realty Trust has a one year low of $6.75 and a one year high of $12.00.

MedEquities Realty Trust (NYSE:MRT) last announced its earnings results on Monday, November 12th. The financial services provider reported ($0.07) earnings per share for the quarter, missing analysts’ consensus estimates of $0.18 by ($0.25). The business had revenue of $9.68 million during the quarter, compared to the consensus estimate of $17.72 million. MedEquities Realty Trust had a return on equity of 3.39% and a net margin of 19.98%. On average, sell-side analysts expect that MedEquities Realty Trust will post 0.8 EPS for the current fiscal year.

In other news, Director Bluemountain Capital Managemen sold 3,955 shares of the company’s stock in a transaction dated Friday, October 5th. The stock was sold at an average price of $9.13, for a total value of $36,109.15. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders sold a total of 441,328 shares of company stock valued at $3,613,650 over the last quarter. Company insiders own 3.00% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of MRT. Renaissance Technologies LLC boosted its holdings in MedEquities Realty Trust by 36.0% during the 2nd quarter. Renaissance Technologies LLC now owns 839,800 shares of the financial services provider’s stock valued at $9,255,000 after acquiring an additional 222,500 shares during the period. BlackRock Inc. boosted its holdings in MedEquities Realty Trust by 14.8% during the 3rd quarter. BlackRock Inc. now owns 1,721,509 shares of the financial services provider’s stock valued at $16,733,000 after acquiring an additional 222,015 shares during the period. Vanguard Group Inc. boosted its holdings in MedEquities Realty Trust by 7.0% during the 3rd quarter. Vanguard Group Inc. now owns 3,151,744 shares of the financial services provider’s stock valued at $30,635,000 after acquiring an additional 205,635 shares during the period. Putnam Investments LLC boosted its holdings in MedEquities Realty Trust by 664.8% during the 3rd quarter. Putnam Investments LLC now owns 178,190 shares of the financial services provider’s stock valued at $1,732,000 after acquiring an additional 154,890 shares during the period. Finally, American Century Companies Inc. boosted its holdings in MedEquities Realty Trust by 7.1% during the 3rd quarter. American Century Companies Inc. now owns 2,325,880 shares of the financial services provider’s stock valued at $22,608,000 after acquiring an additional 153,969 shares during the period. Hedge funds and other institutional investors own 92.13% of the company’s stock.

About MedEquities Realty Trust

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Recommended Story: Google Finance Portfolio Workaround

Analyst Recommendations for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit